N = 837) comprising obese/overweight individuals presenting with a range of metabolic syndrome features but not overt T2D or ischemic heart disease (IHD) (Supplementary Table 1)
Purity is not guaranteed
Kumar J, Liddle EB, Fernandes CC, Palaniyappan L, Hall EL, Robson SE, Simmonite M, Fiesal J, Katshu MZ, Qureshi A, et al
Epitalon stands apart by: Activating telomerase Preserving telomere length Supporting mitochondrial and immune function This makes it a more targeted and systemic solution for cellular longevity
Combining EXE with PIO also suppressed the significant change in body weight induced by PIO compared to weight gain found after its administration
Some patients report less nausea with certain formulations, but this could reflect dose titration speed, individual variability, or placebo effects rather than formulation differences